Staphylococcus Aureus
80
7
8
48
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
13 trials with published results (16%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.0%
8 terminated out of 80 trials
85.7%
-0.8% vs benchmark
14%
11 trials in Phase 3/4
27%
13 of 48 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 48 completed trials
Clinical Trials (80)
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Staph Household Intervention for Eradication (SHINE)
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
Decolonization Efficacy of Polyhexanide vs. Mupirocin
Impact of 18 FDG PET/CT on the Management of Patients With Staphylococcus Aureus Bloodstream Infection
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus
Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis